Global Single-Cell Omics Market: Insights and Forecast

At a Glance:

• Market Size (2023): $1.81 billion

• Projected Market Size (2024): $2.1 billion

• Compound Annual Growth Rate (CAGR): 16.3% (2023-2024)

• Forecasted Market Size (2028): $3.84 billion

• Key Drivers: Cancer prevalence, product innovation, precision medicine

• Major Trends: In vivo studies, multi-omics integration, spatial profiling

• Largest Region (2023): North America

Introduction

The single-cell omics market is experiencing rapid growth, driven by technological advancements and an increasing need for more precise, individualized medical treatments. According to The Business Research Company, the market size is set to expand significantly in the coming years, with projections showing it will grow from $1.81 billion in 2023 to $2.1 billion in 2024, representing a compound annual growth rate (CAGR) of 16.3%.

This growth trend is expected to continue, reaching $3.84 billion by 2028 at a slightly lower CAGR of 16.2%. This article explores the factors fueling the market's expansion, the trends shaping its future, and the key players dominating the sector.

Factors Driving Growth in the Single-Cell Omics Market

Rising Cancer Prevalence

Cancer remains one of the primary drivers of growth in the single-cell omics market. Single-cell omics techniques allow for in-depth analysis of individual cells, enabling researchers to identify biomarkers for early cancer diagnosis, predict disease progression, and discover novel therapeutic targets.

According to the American Cancer Society, the United States saw nearly 1.9 million new cancer cases in 2023, underscoring the growing need for more advanced diagnostic and treatment options. This increasing cancer prevalence is accelerating the adoption of single-cell analysis in oncology research and drug development.

Product Innovation

Another significant factor contributing to market expansion is product innovation. Leading companies in the single-cell omics space are continuously developing new tools and technologies to advance research capabilities.

For example, in May 2023, Deepcell, a software provider specializing in single-cell dimensional morphology analysis, launched its REM-I Platform. This innovative platform offers scalable single-cell imaging, high-dimensional analysis, and cell sorting, providing researchers with unprecedented insights into cell biology, including cancer, stem cell biology, and gene therapy.

Integration with Precision Medicine and Clinical Applications

The integration of single-cell omics with precision medicine is another key factor driving the market. Single-cell analysis enables researchers to explore the complexities of individual cells, which is crucial for the development of personalized treatments.

In particular, this approach is being widely adopted in regenerative medicine, drug discovery, and the development of cellular therapies and immunotherapies.

Major Trends Shaping the Single-Cell Omics Market

In Vivo Single-Cell Studies

In vivo single-cell studies are becoming increasingly popular, allowing researchers to analyze cells in their natural environment rather than in artificial laboratory conditions. This provides a more accurate representation of cellular behavior, leading to more reliable and actionable data.

Single-Cell Multi-Omics Integration

The integration of multiple omics technologies—such as genomics, proteomics, and metabolomics—at the single-cell level is another major trend. This multi-omics approach offers a more comprehensive view of cellular processes and is being used to study complex diseases like cancer and neurodegenerative disorders.

Spatial Single-Cell Profiling

Spatial profiling techniques are gaining traction, as they allow researchers to map the location of individual cells within tissues. This provides deeper insights into how cells interact within their environments, which is essential for understanding complex diseases and developing targeted therapies.

Regional Market Overview

North America was the largest market for single-cell omics in 2023, driven by high healthcare investments, robust research infrastructure, and a strong presence of leading life sciences companies.

However, the market is also witnessing substantial growth in other regions, particularly in Europe and Asia-Pacific, as demand for advanced diagnostic tools and personalized therapies continues to rise globally.

Key Players in the Single-Cell Omics Market

Several major companies are playing a pivotal role in the growth of the single-cell omics market. These include:

• Danaher Corporation

• Merck KGaA

• Becton Dickinson and Company

• GE Healthcare Technologies Inc.

• Thermo Fisher Scientific Inc.

• Agilent Technologies Inc.

• Illumina Inc.

• 10x Genomics Inc.

• Deepcell (as noted above)

• NanoString Technologies Inc.

These companies are driving innovation, with a focus on creating more advanced tools for single-cell analysis, expanding the potential applications of omics technologies in drug discovery, cancer research, and personalized medicine.

Conclusion

The single-cell omics market is poised for substantial growth, driven by technological advancements, an increasing need for personalized medicine, and the rising prevalence of cancer. As product innovations continue to shape the landscape and the integration of multi-omics approaches gains momentum, the market will offer ample opportunities for stakeholders in research, diagnostics, and drug development.

The Business Research Company’s comprehensive market report provides invaluable insights into current trends, market forecasts, and competitive dynamics, helping stakeholders make informed decisions and stay ahead in this rapidly evolving field.

For more detailed insights into the global single-cell omics market, access the complete report at The Business Research Company.